α7 Nicotinic acetylcholine receptor activation rescues mitochondrial dysfunction in gestational diabetes mellitus by competing with p66Shc for VDAC1 binding
- Diabetologia. 2025 Dec 15. doi: 10.1007/s00125-025-06640-y.
- 1. Department of Histology and Embryology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, China.
- 2. Department of Human Anatomy, Basic Medical Sciences of Xinxiang Medical University, Xinxiang, China.
- 3. Department of Ultrasound in Gynecology and Obstetrics, Zhongnan Hospital of Wuhan University, Wuhan, China.
- 4. Department of Histology and Embryology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, China. [email protected].
- 5. Department of Histology and Embryology, TaiKang Medical School (School of Basic Medical Sciences), Wuhan University, Wuhan, China. [email protected].
- 6. Hubei Provincial Key Laboratory of Developmentally Originated Disease, Wuhan, China. [email protected].
- # Contributed equally.
Aims/hypothesis: Gestational diabetes mellitus (GDM) is associated with placental hormone-induced Insulin resistance; however, the mechanisms connecting hyperglycaemia to mitochondrial dysfunction remain incompletely understood. This study aimed to investigate the role of the α7 nicotinic acetylcholine receptor (α7nAChR) in regulating mitochondrial CA2⁺ homeostasis in trophoblasts under hyperglycaemic stress, and to explore whether its dysregulation contributes to placental mitochondrial pathology in GDM.
Methods: Clinical placental samples from GDM pregnancies were analysed to assess α7nAChR expression, mitochondrial morphology and CA2⁺ signalling pathways. Complementary in vitro and murine models of hyperglycaemia were employed to examine molecular interactions involving α7nAChR, voltage-dependent anion channel 1 (VDAC1) and p66Shc. Mitochondrial-associated endoplasmic reticulum membranes were studied to evaluate pathological CA2⁺ transfer mechanisms. Pharmacological activation of α7nAChR was performed using PNU-282987 (PNU) or GTS-21, and RNA-seq was conducted to analyse downstream transcriptional changes related to mitochondrial dysfunction and cellular senescence.
Results: Clinical analysis revealed reduced α7nAChR expression, mitochondrial vacuolisation and dysregulated CA2⁺ signalling pathways in GDM placentas. Under hyperglycaemic conditions, disrupted α7nAChR-VDAC1 interactions facilitated competitive binding of the pro-oxidant p66Shc to VDAC1, promoting pathological CA2⁺ transfer from the endoplasmic reticulum to mitochondria via mitochondrial-associated endoplasmic reticulum membranes. This led to mitochondrial permeability transition pore overactivation, loss of mitochondrial membrane potential and induction of cellular senescence. Pharmacological activation of α7nAChR with PNU or GTS-21 restored α7nAChR-VDAC1 coupling, attenuated p66Shc-mediated oxidative stress and reversed mitochondrial CA2⁺ overload. RNA-seq confirmed that PNU treatment normalised gene expression profiles associated with endoplasmic reticulum stress and cellular senescence.
Conclusions/interpretation: This study identifies a non-canonical role for α7nAChR in maintaining mitochondrial CA2⁺ homeostasis by competitively regulating VDAC1-p66Shc interactions under hyperglycaemic conditions. The findings reveal a mechanistic link between α7nAChR dysfunction, mitochondrial CA2⁺ overload and cellular senescence in GDM placentas. Targeting α7nAChR with pharmacological agents such as GTS-21 may offer a novel therapeutic approach to ameliorate mitochondrial dysfunction and placental pathology in GDM by restoring CA2⁺ dynamics.
-
Cat. No.Product NameDescriptionTargetResearch Area
-
Research Areas: Infection
-
target: nAChRResearch Areas: Neurological Disease
-
Research Areas: Inflammation/Immunology
-
Cat. No.Product NameCategory/Application